Origin > Big Thinkers > Robert A. Freitas Jr.
Printable Version
   

Robert A. Freitas Jr.

Robert A. Freitas Jr. is Senior Research Fellow at the Institute for Molecular Manufacturing (IMM) in Palo Alto, California, and was a Research Scientist at Zyvex Corp. (Richardson, Texas), the first molecular nanotechnology company, during 2000-2004. He received B.S. degrees in Physics and Psychology from Harvey Mudd College in 1974 and a J.D. from University of Santa Clara in 1979. Freitas co-edited the 1980 NASA feasibility analysis of self-replicating space factories and in 1996 authored the first detailed technical design study of a medical nanorobot ever published in a peer-reviewed mainstream biomedical journal. More recently, Freitas is the author of Nanomedicine, the first book-length technical discussion of the potential medical applications of molecular nanotechnology and medical nanorobotics; the first two volumes of this 4-volume series were published in 1999 and 2003 by Landes Bioscience. His research interests include: nanomedicine, medical nanorobotics design, molecular machine systems, diamond mechanosynthesis (theory and experimental pathways), molecular assemblers and nanofactories, and self-replication in machine and factory systems. He has published 25 refereed journal publications and several contributed book chapters, and most recently co-authored Kinematic Self-Replicating Machines (2004), another first-of-its-kind technical treatise.

 
   
Articles on KurzweilAI.net written by Robert A. Freitas Jr.:
Lifeboat Foundation Nanoshield
Economic Impact of the Personal Nanofactory
What Price Freedom?
Molecular Manufacturing: Too Dangerous to Allow?
Nanotechnology, Nanomedicine and Nanosurgery
Interview with Robert A. Freitas Jr. Part 2
Interview with Robert A. Freitas Jr. Part 1
How To Make a Nanodiamond
Nanomedicine
Death is an Outrage
The Vasculoid Personal Appliance
Tangible Nanomoney
Respirocytes
Clottocytes: Artificial Mechanical Platelets
Microbivores: Artificial Mechanical Phagocytes
Robots in the bloodstream: the promise of nanomedicine
Say Ah
The Gray Goo Problem